TGFB1 and breast carcinoma: Quarmby et al (2003), first reported a significant association between the TGFβ1 (C-509T) polymorphism in Caucasian breast cancer patients who had received a similar radiotherapy dose (40 Gy in 15 fractions) to those used in this study (Table 1).